Scientists have identified a pair of neutralizing antibodies – isolated from a patient who recovered from COVID-19 – that bind to the glycoprotein spike of the SARS-CoV-2 virus, blocking the spike’s ability to bind to the human ACE2 receptor and mediate viral entry into host cells.
- Racial disparities in COVID-19 are clear; better data, more targeted action needed
- Study links attraction to ‘tyrannical’ leaders to dysfunctional family dynamics
- Scientists demonstrate a new experiment in the search for theorized ‘neutrinoless’ proc
- 1 in 3 young adults may face severe COVID-19, UCSF study shows
- Mothers, newborns, young children and adolescents lose 20% of health and social services to COVID-19